Cigarette Smoking, and Blood Monocyte Count Correlate with Chronic Lung Injuries and Mortality

References

• CDC. Health effects of cigarette smoking; 2022. Available from: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm#references. Accessed August 24, 2022.
   Google Scholar
• Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242–248. doi:10.1164/ajrccm.155.1.9001319
   PubMed Web of Science ®Google Scholar
• Bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med. 2002;23(1):1–25. doi:10.1016/s0272-5231(03)00057-1
   PubMedGoogle Scholar
• Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011;11:36. doi:10.1186/1471-2466-11-36
   PubMed Web of Science ®Google Scholar
• Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the multi-ethnic study of atherosclerosis (Mesa)-lung study. Am J Respir Crit Care Med. 2009;180(5):407–414. doi:10.1164/rccm.200812-1966OC
   PubMed Web of Science ®Google Scholar
• Beghe B, Cerri S, Fabbri LM, Marchioni A. COPD, pulmonary fibrosis and ILAs in aging smokers: the paradox of striking different responses to the major risk factors. Int J Mol Sci. 2021;22(17). doi:10.3390/ijms22179292
   Google Scholar
• Ridge CA, McErlean AM, Ginsberg MS. Epidemiology of lung cancer. Semin Intervent Radiol. 2013;30(2):93–98. doi:10.1055/s-0033-1342949
   PubMed Web of Science ®Google Scholar
• Bergmann S, Siekmeier R, Mix C, Jaross W. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respir Physiol. 1998;114(3):269–275. doi:10.1016/s0034-5687(98)00098-x
   PubMedGoogle Scholar
• Pedersen KM, Colak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG. Smoking and increased white and red blood cells. Arterioscler Thromb Vasc Biol. 2019;39(5):965–977. doi:10.1161/ATVBAHA.118.312338
   PubMed Web of Science ®Google Scholar
• Smith CJ, Kluck LA, Ruan GJ, et al. Leukocytosis and tobacco use: an observational study of asymptomatic leukocytosis. Am J Med. 2021;134(1):e31–e35. doi:10.1016/j.amjmed.2020.06.014
   PubMed Web of Science ®Google Scholar
• Achaiah A, Lyon P, Fraser E, et al. Increased monocyte level is a risk factor for radiological progression in patients with early fibrotic interstitial lung abnormality. ERJ Open Res. 2022;8(3). doi:10.1183/23120541.00226-2022
   PubMedGoogle Scholar
• Achaiah A, Rathnapala A, Pereira A, et al. Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern. BMJ Open Respir Res. 2021;8(1). doi:10.1136/bmjresp-2021-000899
   PubMedGoogle Scholar
• Cornwell WD, Kim V, Fan X, et al. Activation and polarization of circulating monocytes in severe chronic obstructive pulmonary disease. BMC Pulm Med. 2018;18(1):101. doi:10.1186/s12890-018-0664-y
   PubMed Web of Science ®Google Scholar
• Kapellos TS, Bonaguro L, Gemund I, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10:2035. doi:10.3389/fimmu.2019.02035
   PubMed Web of Science ®Google Scholar
• Kim JS, Axelsson GT, Moll M, et al. Associations of monocyte count and other immune cell types with interstitial lung abnormalities. Am J Respir Crit Care Med. 2022;205(7):795–805. doi:10.1164/rccm.202108-1967OC
   PubMedGoogle Scholar
• Kreuter M, Lee JS, Tzouvelekis A, et al. Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2021;204(1):74–81. doi:10.1164/rccm.202003-0669OC
   PubMed Web of Science ®Google Scholar
• Scott MKD, Quinn K, Li Q, et al. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Lancet Respir Med. 2019;7(6):497–508. doi:10.1016/S2213-2600(18)30508-3
   PubMedGoogle Scholar
• Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity. 2018;49(4):595–613. doi:10.1016/j.immuni.2018.10.005
   PubMed Web of Science ®Google Scholar
• Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood. 1993;82(10):3170–3176.
   PubMedGoogle Scholar
• Nockher WA, Scherberich JE. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun. 1998;66(6):2782–2790. doi:10.1128/IAI.66.6.2782-2790.1998
   PubMedGoogle Scholar
• Ziegler-Heitbrock L. Blood monocytes and their subsets: established features and open questions. Front Immunol. 2015;6:423. doi:10.3389/fimmu.2015.00423
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958–969. doi:10.1038/nri2448
   PubMed Web of Science ®Google Scholar
• Lugg ST, Scott A, Parekh D, Naidu B, Thickett DR. Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease. Thorax. 2022;77(1):94–101. doi:10.1136/thoraxjnl-2020-216296
   PubMed Web of Science ®Google Scholar
• Elisia I, Lam V, Cho B, et al. The effect of smoking on chronic inflammation, immune function and blood cell composition. Sci Rep. 2020;10(1):19480. doi:10.1038/s41598-020-76556-7
   PubMed Web of Science ®Google Scholar
• Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco Smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review. Int J Environ Res Public Health. 2018;15(5). doi:10.3390/ijerph15051033
   PubMedGoogle Scholar
• Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669–692. doi:10.1146/annurev.immunol.021908.132557
   PubMed Web of Science ®Google Scholar
• Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71–82.
   PubMed Web of Science ®Google Scholar
• Hoogsteden HC, van Dongen JJ, van Hal PT, Delahaye M, Hop W, Hilvering C. Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease. Chest. 1989;95(3):574–577. doi:10.1378/chest.95.3.574
   PubMedGoogle Scholar
• Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211(6–8):609–618. doi:10.1016/j.imbio.2006.05.025
   PubMed Web of Science ®Google Scholar
• Barman PK, Shin JE, Lewis SA, et al. Production of MHCII-expressing classical monocytes increases during aging in mice and humans. Aging Cell. 2022;21(10):e13701. doi:10.1111/acel.13701
   PubMedGoogle Scholar
• Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediators Inflamm. 2015;2015:692546. doi:10.1155/2015/692546
   PubMed Web of Science ®Google Scholar
• Puissant-Lubrano B, Apoil PA, Guedj K, et al. Distinct effect of age, sex, and CMV seropositivity on dendritic cells and monocytes in human blood. Immunol Cell Biol. 2018;96(1):114–120. doi:10.1111/imcb.1004
   PubMedGoogle Scholar
• Fernandez IE, Kass DJ. Do circulating monocytes promote and predict idiopathic pulmonary fibrosis progression? Am J Respir Crit Care Med. 2021;204(1):9–11. doi:10.1164/rccm.202101-0207ED
   PubMedGoogle Scholar
• Oliveira da Silva C, Monte-Alto-Costa A, Renovato-Martins M, et al. Time course of the phenotype of blood and bone marrow monocytes and macrophages in the lung after cigarette smoke exposure in vivo. Int J Mol Sci. 2017;18(9). doi:10.3390/ijms18091940
   PubMedGoogle Scholar
• Sangani RG, Deepak V, Ghio AJ, et al. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection. BMC Pulm Med. 2022;22(1):172. doi:10.1186/s12890-022-01961-9
   PubMedGoogle Scholar
• Prevention WDoT. Smoking Cessation; 2022. Available from: https://dhhr.wv.gov/wvdtp/cessation/pages/default.aspx. Accessed September 1, 2022.
   Google Scholar
• Cardarelli K, Westneat S, Dunfee M, May B, Schoenberg N, Browning S. Persistent disparities in smoking among rural Appalachians: evidence from the mountain air project. BMC Public Health. 2021;21(1):270. doi:10.1186/s12889-021-10334-6
   PubMed Web of Science ®Google Scholar
• Gouveia TDS, Trevisan IB, Santos CP, et al. Smoking history: relationships with inflammatory markers, metabolic markers, body composition, muscle strength, and cardiopulmonary capacity in current smokers. J Bras Pneumol. 2020;46(5):e20180353. doi:10.36416/1806-3756/e20180353
   PubMedGoogle Scholar
• Terashima T, Wiggs B, English D, Hogg JC, van Eeden SF. The effect of cigarette smoking on the bone marrow. Am J Respir Crit Care Med. 1997;155(3):1021–1026. doi:10.1164/ajrccm.155.3.9116981
   PubMedGoogle Scholar
• Goto Y, Ishii H, Hogg JC, et al. Particulate matter air pollution stimulates monocyte release from the bone marrow. Am J Respir Crit Care Med. 2004;170(8):891–897. doi:10.1164/rccm.200402-235OC
   PubMed Web of Science ®Google Scholar
• Nemmar A, Inuwa IM. Diesel exhaust particles in blood trigger systemic and pulmonary morphological alterations. Toxicol Lett. 2008;176(1):20–30. doi:10.1016/j.toxlet.2007.09.006
   PubMed Web of Science ®Google Scholar
• Su TC, Hwang JJ, Yang YR, Chan CC. Association between long-term exposure to traffic-related air pollution and inflammatory and thrombotic markers in middle-aged adults. Epidemiology. 2017;28(Suppl 1):S74–S81. doi:10.1097/EDE.0000000000000715
   PubMedGoogle Scholar
• Fessler MB, Carnes MU, Salo PM, et al. House dust endotoxin and peripheral leukocyte counts: results from two large epidemiologic studies. Environ Health Perspect. 2017;125(5):057010. doi:10.1289/EHP661
   PubMedGoogle Scholar
• Karakaya A, Yucesoy B, Sardas OS. An immunological study on workers occupationally exposed to cadmium. Hum Exp Toxicol. 1994;13(2):73–75. doi:10.1177/096032719401300202
   PubMedGoogle Scholar
• Byrne AJ, Powell JE, O’Sullivan BJ, et al. Dynamics of human monocytes and airway macrophages during healthy aging and after transplant. J Exp Med. 2020;217(3). doi:10.1084/jem.20191236
   PubMedGoogle Scholar
• Gibbings SL, Goyal R, Desch AN, et al. Transcriptome analysis highlights the conserved difference between embryonic and postnatal-derived alveolar macrophages. Blood. 2015;126(11):1357–1366. doi:10.1182/blood-2015-01-624809
   PubMedGoogle Scholar
• Misharin AV, Morales-Nebreda L, Reyfman PA, et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med. 2017;214(8):2387–2404. doi:10.1084/jem.20162152
   PubMed Web of Science ®Google Scholar
• Klotz O. Pulmonary anthracosis -a community disease. Am J Public Health. 1914;4(10):887–916. doi:10.2105/ajph.4.10.887
   Google Scholar
• Pinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20–29 pack-year smokers: implications for screening. J Natl Cancer Inst. 2015;107(11). doi:10.1093/jnci/djv226
   PubMedGoogle Scholar
• Force US, Krist AH, Davidson KW, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021;325(10):962–970. doi:10.1001/jama.2021.1117
   PubMed Web of Science ®Google Scholar
• Bellou V, Belbasis L, Evangelou E. Tobacco smoking and risk for pulmonary fibrosis: a prospective cohort study from the UK biobank. Chest. 2021;160(3):983–993. doi:10.1016/j.chest.2021.04.035
   PubMedGoogle Scholar
• Weiss W. Smoking and pulmonary fibrosis. J Occup Med. 1988;30(1):33–39.
   PubMedGoogle Scholar
• Fraser E, Denney L, Antanaviciute A, et al. Multi-modal characterization of monocytes in idiopathic pulmonary fibrosis reveals a primed type I interferon immune phenotype. Front Immunol. 2021;12:623430. doi:10.3389/fimmu.2021.623430
   PubMedGoogle Scholar
• Teoh AKY, Jo HE, Chambers DC, et al. Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry. Eur Respir J. 2020;55(4). doi:10.1183/13993003.01855-2019
   PubMedGoogle Scholar
• Osaka D, Shibata Y, Abe S, et al. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata study. Intern Med. 2010;49(15):1489–1499. doi:10.2169/internalmedicine.49.3364
   PubMed Web of Science ®Google Scholar
• McKeever T, Saha S, Fogarty AW. The association between systemic inflammatory cellular levels and lung function: a population-based study. PLoS One. 2011;6(7):e21593. doi:10.1371/journal.pone.0021593
   PubMed Web of Science ®Google Scholar
• Wu X, Wang C, Li H, et al. Circulating white blood cells and lung function impairment: the observational studies and Mendelian randomization analysis. Ann Med. 2021;53(1):1118–1128. doi:10.1080/07853890.2021.1948603
   PubMed Web of Science ®Google Scholar
• Lubin JH, Caporaso NE. Misunderstandings in the misconception on the use of pack-years in analysis of smoking. Br J Cancer. 2013;108(5):1218–1220. doi:10.1038/bjc.2013.76
   PubMedGoogle Scholar
• Peto J. That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer. 2012;107(3):406–407. doi:10.1038/bjc.2012.97
   PubMed Web of Science ®Google Scholar
• Pleasants RA, Rivera MP, Tilley SL, Bhatt SP. Both duration and pack-years of tobacco smoking should be used for clinical practice and research. Ann Am Thorac Soc. 2020;17(7):804–806. doi:10.1513/AnnalsATS.202002-133VP
   PubMedGoogle Scholar
• Patel AA, Yona S. Inherited and environmental factors influence human monocyte heterogeneity. Front Immunol. 2019;10:2581. doi:10.3389/fimmu.2019.02581
   PubMedGoogle Scholar
• Barnes PJ. Sex differences in chronic obstructive pulmonary disease mechanisms. Am J Respir Crit Care Med. 2016;193(8):813–814. doi:10.1164/rccm.201512-2379ED
   PubMed Web of Science ®Google Scholar
• Radkiewicz C, Dickman PW, Johansson ALV, Wagenius G, Edgren G, Lambe M. Sex and survival in non-small cell lung cancer: a nationwide cohort study. PLoS One. 2019;14(6):e0219206. doi:10.1371/journal.pone.0219206
   PubMed Web of Science ®Google Scholar
• Hlapcic I, Dugac AV, Popovic-Grle S, et al. Influence of disease severity, smoking status and therapy regimes on leukocyte subsets and their ratios in stable chronic obstructive pulmonary disease. Arch Med Sci. 2022;18(3):672–681. doi:10.5114/aoms.2020.100720
   PubMedGoogle Scholar
• Yang J, Qiao M, Li Y, et al. Expansion of a population of large monocytes (atypical monocytes) in peripheral blood of patients with acute exacerbations of chronic obstructive pulmonary diseases. Mediators Inflamm. 2018;2018:9031452. doi:10.1155/2018/9031452
   PubMed Web of Science ®Google Scholar
• Hai Y, Chen N, Wu W, et al. High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy. BMC Cancer. 2018;18(1):1011. doi:10.1186/s12885-018-4909-1
   PubMedGoogle Scholar
• Kumagai S, Marumo S, Shoji T, et al. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Lung Cancer. 2014;85(3):457–464. doi:10.1016/j.lungcan.2014.06.015
   PubMed Web of Science ®Google Scholar
• Van Tiel E, Peeters PH, Smit HA, et al. Quitting smoking may restore hematological characteristics within five years. Ann Epidemiol. 2002;12(6):378–388. doi:10.1016/s1047-2797(01)00282-4
   PubMed Web of Science ®Google Scholar
• Leifert JA. Anaemia and cigarette smoking. Int J Lab Hematol. 2008;30(3):177–184. doi:10.1111/j.1751-553X.2008.01067.x
   PubMed Web of Science ®Google Scholar
• Spivak JL. Cancer-related anemia: its causes and characteristics. Semin Oncol. 1994;21(2 Suppl 3):3–8.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214–2221.
   PubMed Web of Science ®Google Scholar
• Gurun Kaya A, Ozyurek BA, Sahin Ozdemirel T, Oz M, Erdogan Y. Prognostic significance of red cell distribution width in idiopathic pulmonary fibrosis and combined pulmonary fibrosis emphysema. Med Princ Pract. 2021;30(2):154–159. doi:10.1159/000511106
   PubMedGoogle Scholar
• Sarkar M, Rajta PN, Khatana J. Anemia in chronic obstructive pulmonary disease: prevalence, pathogenesis, and potential impact. Lung India. 2015;32(2):142–151. doi:10.4103/0970-2113.152626
   PubMedGoogle Scholar
• Balasubramanian A, Putcha N, MacIntyre NR, et al. Diffusing capacity and mortality in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2022. doi:10.1513/AnnalsATS.202203-226OC
   Google Scholar
• Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431–440. doi:10.1164/rccm.201006-0894CI
   PubMed Web of Science ®Google Scholar
• Liber AC, Warner KE. Has underreporting of cigarette consumption changed over time? Estimates derived from US national health surveillance systems between 1965 and 2015. Am J Epidemiol. 2018;187(1):113–119. doi:10.1093/aje/kwx196
   PubMedGoogle Scholar
• Anderson AE Jr., Hernandez JA, Eckert P, Foraker AG. Emphysema in lung macrosections correlated with smoking habits. Science. 1964;144(3621):1025–1026. doi:10.1126/science.144.3621.1025
   PubMedGoogle Scholar
• Auerbach O, Hammond EC, Garfinkel L, Benante C. Relation of smoking and age to emphysema. Whole-lung section study. N Engl J Med. 1972;286(16):853–857. doi:10.1056/NEJM197204202861601
   PubMedGoogle Scholar
• Gillooly M, Lamb D. Microscopic emphysema in relation to age and smoking habit. Thorax. 1993;48(5):491–495. doi:10.1136/thx.48.5.491
   PubMedGoogle Scholar